UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 10-Q
(Mark One)
☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended July 1, 2022
OR
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from __ to __
Commission File Number: 001-37961
ICHOR HOLDINGS, LTD.
(Exact Name of Registrant as Specified in its Charter)
Cayman Islands
Not Applicable
( State or other jurisdiction of
incorporation or organization)
(I.R.S. EmployerIdentification No.)
3185 Laurelview Ct.
Fremont, CA
94538
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code: (510) 897-5200
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Ordinary Shares, par value $0.0001
ICHR
The NASDAQ Stock Market LLC
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S‑T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non‑accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b‑2 of the Exchange Act.
Large accelerated filer
Accelerated filer
Non‑accelerated filer
Small reporting company
Emerging Growth Company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b‑2 of the Exchange Act). Yes ☐ No ☒
As of August 5, 2022, the registrant had 28,739,608 ordinary shares, $0.0001 par value per share, outstanding.
TABLE OF CONTENTS
PART I
ITEM 1.
FINANCIAL STATEMENTS (UNAUDITED)
1
ITEM 2.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
14
ITEM 3.
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
21
ITEM 4.
CONTROLS AND PROCEDURES
22
PART II
LEGAL PROCEEDINGS
23
ITEM 1A.
RISK FACTORS
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
DEFAULTS UPON SENIOR SECURITIES
MINE SAFETY DISCLOSURES
ITEM 5.
OTHER INFORMATION
ITEM 6.
EXHIBITS
SIGNATURES
24
ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)
Consolidated Balance Sheets
(dollars in thousands, except per share amounts)
(unaudited)
July 1,
2022
December 31,
2021
Assets
Current assets:
Cash and cash equivalents
$
46,064
75,495
Accounts receivable, net
158,403
142,990
Inventories
290,327
236,133
Prepaid expenses and other current assets
5,699
8,153
Total current assets
500,493
462,771
Property and equipment, net
91,603
85,204
Operating lease right-of-use assets
35,649
29,790
Other noncurrent assets
12,887
9,166
Deferred tax assets, net
9,247
8,116
Intangible assets, net
79,923
89,927
Goodwill
335,902
Total assets
1,065,704
1,020,876
Liabilities and Shareholders’ Equity
Current liabilities:
Accounts payable
147,650
159,727
Accrued liabilities
21,652
19,066
Other current liabilities
14,162
14,377
Current portion of long-term debt
7,500
Current portion of lease liabilities
7,956
7,633
Total current liabilities
198,920
208,303
Long-term debt, less current portion, net
296,736
285,253
Lease liabilities, less current portion
28,063
22,354
Deferred tax liabilities, net
38
Other non-current liabilities
4,623
4,213
Total liabilities
528,380
520,161
Shareholders’ equity:
Preferred shares ($0.0001 par value; 20,000,000 shares authorized; zero shares issued and outstanding)
—
Ordinary shares ($0.0001 par value; 200,000,000 shares authorized; 28,735,728 and 28,551,160 shares outstanding, respectively; 33,173,167 and 32,988,599 shares issued, respectively)
3
Additional paid in capital
424,471
417,438
Treasury shares at cost (4,437,439 shares)
(91,578
)
Accumulated other comprehensive loss
Retained earnings
204,428
174,852
Total shareholders’ equity
537,324
500,715
Total liabilities and shareholders’ equity
See accompanying notes.
Consolidated Statements of Operations
Three Months Ended
Six Months Ended
June 25,
Net sales
329,560
282,308
622,706
546,874
Cost of sales
274,099
234,955
523,313
460,009
Gross profit
55,461
47,353
99,393
86,865
Operating expenses:
Research and development
4,907
4,049
9,758
7,564
Selling, general, and administrative
21,103
14,699
44,370
29,048
Amortization of intangible assets
4,655
3,390
10,004
6,781
Total operating expenses
30,665
22,138
64,132
43,393
Operating income
24,796
25,215
35,261
43,472
Interest expense, net
2,063
1,591
3,595
3,510
Other expense (income), net
(548
(464
207
Income before income taxes
23,281
23,602
32,130
39,755
Income tax expense
1,744
737
2,554
2,252
Net income
21,537
22,865
29,576
37,503
Net income per share:
Basic
0.75
0.81
1.03
1.33
Diluted
0.74
0.79
1.02
1.30
Shares used to compute net income per share:
28,665,930
28,180,821
28,629,280
28,092,535
29,042,519
29,092,521
28,948,055
28,942,902
2
Consolidated Statements of Comprehensive Income
(in thousands)
Other comprehensive loss, net of tax:
Unrealized loss on available-for-sale marketable securities
(24
Comprehensive income
22,841
37,479
Consolidated Statements of Shareholders’ Equity
(dollars in thousands)
Additional
Treasury
Accumulated
Total
For the three months ending July 1, 2022
Ordinary Shares
Paid-In
Shares
Other Comprehensive
Retained
Shareholders'
Amount
Capital
Income (Loss)
Earnings
Equity
Balance at April 1, 2022
28,628,907
420,513
4,437,439
182,891
511,829
Ordinary shares issued from exercise of stock options
5,015
83
Ordinary shares issued from vesting of restricted share units
59,741
(563
Ordinary shares issued from employee share purchase plan
42,065
929
Share-based compensation expense
3,509
Balance at July 1, 2022
28,735,728
For the six months ending July 1, 2022
Balance at December 31, 2021
28,551,160
47,768
1,038
94,735
(1,340
6,406
4
Consolidated Statements of Shareholders’ Equity (continued)
For the three months ending June 25, 2021
Balance at March 26, 2021
28,070,251
404,046
118,591
431,062
179,131
3,150
77,177
(1,251
2,681
Other comprehensive loss
Balance at June 25, 2021
28,326,559
408,626
141,456
458,483
For the six months ending June 25, 2021
Balance at December 25, 2020
27,907,077
399,311
103,953
411,689
284,731
5,531
107,600
(1,918
27,151
606
5,096
5
Consolidated Statements of Cash Flows
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization
18,394
11,464
Share-based compensation
Deferred income taxes
(1,131
1,089
Amortization of debt issuance costs
233
483
Gain on sale of asset disposal group
(504
Other
59
Changes in operating assets and liabilities, net of acquisitions:
(15,413
(18,131
(54,194
(31,500
Prepaid expenses and other assets
2,461
(478
(12,453
33,302
2,586
(952
Other liabilities
(3,360
1,458
Net cash provided by (used in) operating activities
(26,895
38,889
Cash flows from investing activities:
Capital expenditures
(14,413
(15,369
Purchase of marketable securities
(105,033
Proceeds from sale of property and equipment
504
Net cash used in investing activities
(119,898
Cash flows from financing activities:
Issuance of ordinary shares under share-based compensation plans
1,967
6,117
Employees' taxes paid upon vesting of restricted share units
Borrowings on revolving credit facility
25,000
Repayments on revolving credit facility
(10,000
(30,000
Repayments on term loan
(3,750
(4,375
Net cash provided by (used in) financing activities
11,877
(30,176
Net decrease in cash
(29,431
(111,185
Cash at beginning of period
252,899
Cash at end of period
141,714
Supplemental disclosures of cash flow information:
Cash paid during the period for interest
3,295
3,341
Cash paid during the period for taxes, net of refunds
1,499
1,272
Supplemental disclosures of non-cash activities:
Capital expenditures included in accounts payable
1,306
246
Right-of-use assets obtained in exchange for new operating lease liabilities, including those acquired through acquisitions
9,587
1,709
6
Notes to Consolidated Financial Statements
(dollar figures in tables in thousands, except per share amounts)
Note 1 – Basis of Presentation and Selected Significant Accounting Policies
Basis of Presentation
These consolidated unaudited financial statements have been prepared in accordance with generally accepted accounting principles in the U.S. (“GAAP”). All intercompany balances and transactions have been eliminated upon consolidation. All dollar figures presented in tables in the notes to consolidated financial statements are in thousands, except per share amounts. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted as permitted by the SEC's rules and regulations for interim reporting. These consolidated financial statements should be read in conjunction with our audited financial statements and notes thereto included in our Annual Report on Form 10‑K for the year ended December 31, 2021.
Year End
We use a 52- or 53-week fiscal year ending on the last Friday in December. The three months ended July 1, 2022 and June 25, 2021 were both 13 weeks. References to the second quarter of 2022 and 2021 refer to the three-month periods then ended. References to fiscal year 2022 and 2021 refer to our fiscal years ending December 30, 2022 and December 31, 2021, respectively. Fiscal year 2022 and 2021 are 52 and 53 weeks, respectively.
Use of Estimates
The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods presented. We base our estimates and judgments on historical experience and on various other assumptions that we believe are reasonable under the circumstances. Actual results could differ from the estimates made by management. Significant estimates include inventory valuation and impairment analysis for both definite‑lived intangible assets and goodwill.
Cash and Cash Equivalents
Cash and cash equivalents consist of deposits and financial instruments which are readily convertible into cash and have original maturities of 90 days or less at the time of acquisition.
Fair Value of Financial Instruments
The carrying values of our financial instruments, including cash and cash equivalents, accounts receivable, prepaid expenses and other current assets, accounts payable, accrued liabilities, and long-term debt, net of unamortized debt issuance costs, approximate fair value.
Revenue Recognition
We recognize revenue when control of promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. This amount is recorded as net sales in our consolidated statements of operations.
Transaction price – In most of our contracts, prices are generally determined by a customer-issued purchase order and generally remain fixed over the duration of the contract. Certain contracts contain variable consideration, including early-payment discounts and rebates. When a contract includes variable consideration, we evaluate the estimate of the variable consideration to determine whether the estimate needs to be constrained; therefore, we include the variable consideration in the transaction price only to the extent that it is probable that a significant reversal will not occur. Variable consideration estimates are updated at each reporting date. Historically, we have not incurred significant costs to obtain a contract. All amounts billed to a customer relating to shipping and handling are classified as net sales, while all costs incurred by us for shipping and handling are classified as cost of sales.
7
Performance obligations – Substantially all of our performance obligations pertain to promised goods (“products”), which are primarily comprised of fluid delivery subsystems, weldments, and other components. Most of our contracts contain a single performance obligation and are generally completed within twelve months. Product sales are recognized at a point-in-time, generally upon delivery, as such term is defined within the contract, as that is when control of the promised good has transferred. Products are covered by a standard assurance warranty, generally extended for a period of one to two years depending on the customer, which promises that delivered products conform to contract specifications. As such, we account for such warranties under ASC 460, Guarantees, and not as a separate performance obligation.
Contract balances – Accounts receivable represents our unconditional right to receive consideration from our customers. Accounts receivable are carried at invoice price less an estimate for doubtful accounts and estimated payment discounts. Payment terms vary by customer but are generally due within 15‑60 days. Historically, we have not incurred significant payment issues with our customers. We had no significant contract assets or liabilities on our consolidated balance sheets in any of the periods presented.
Accounting Pronouncements Recently Adopted
In October 2021, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2021‑08, Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (Topic 805). This ASU requires an acquirer in a business combination to recognize and measure contract assets and contract liabilities (deferred revenue) from acquired contracts using the revenue recognition guidance in Topic 606. At the acquisition date, the acquirer applies the revenue model as if it had originated the acquired contracts. The ASU is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Adoption of the ASU should be applied prospectively. Early adoption is also permitted, including adoption in an interim period. If early adopted, the amendments are applied retrospectively to all business combinations for which the acquisition date occurred during the fiscal year of adoption. This ASU is currently not expected to have a material impact on our consolidated financial statements.
Note 2 – Inventories
Inventories consist of the following:
Raw materials
201,966
159,366
Work in process
68,918
62,537
Finished goods
34,793
28,281
Excess and obsolete adjustment
(15,350
(14,051
Total inventories
Note 3 – Property and Equipment and Other Noncurrent Assets
Property and equipment consist of the following:
Machinery
87,403
80,953
Leasehold improvements
40,732
36,706
Computer software, hardware, and equipment
9,370
8,031
Office furniture, fixtures and equipment
1,258
1,168
Vehicles
325
284
Construction-in-process
11,274
8,565
150,362
135,707
Less accumulated depreciation
(58,759
(50,503
Total property and equipment, net
Depreciation expense was $4.4 million and $2.4 million for the second quarter of 2022 and 2021, respectively. Depreciation expense was $8.4 million and $4.7 million for the six months ended July 1, 2022 and June 25, 2021, respectively.
8
Cloud Computing Implementation Costs
We capitalize implementation costs associated with hosting arrangement that are service contracts. These costs are recorded to prepaid expenses or other noncurrent assets. To-date, these costs are those incurred to implement a new company-wide ERP system.
The following table summarizes capitalized cloud computing implementation costs:
Capitalized cloud computing implementation costs as of December 31, 2021
8,054
Costs capitalized during the period
4,073
Capitalized costs amortized during the period
(399
Capitalized cloud computing implementation costs as of July 1, 2022
11,728
Note 4 – Intangible Assets
Definite‑lived intangible assets consist of the following:
July 1, 2022
Gross value
amortization
impairment
charges
Carrying
amount
Weighted
average
useful life
Customer relationships
117,022
(44,140
72,882
8.4 years
Developed technology
11,047
(4,006
7,041
10.0 years
Total intangible assets
128,069
(48,146
December 31, 2021
146,569
(65,953
80,616
8.7 years
(3,483
Order backlog
2,600
(853
1,747
6 months
160,216
(70,289
Note 5 – Leases
Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. For purposes of calculating operating lease ROU assets and operating lease liabilities, we use the non-cancellable lease term plus options to extend that we are reasonably certain to take. Lease expense for operating lease payments is recognized on a straight-line basis over the lease term. Our leases generally do not provide an implicit rate. As such, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments.
We lease facilities under various non-cancellable operating leases expiring through 2031. In addition to base rental payments, we are generally responsible for our proportionate share of operating expenses, including facility maintenance, insurance, and property taxes. As these amounts are variable, they are not included in lease liabilities. As of July 1, 2022, we had one operating lease executed for which the rental period had not yet commenced.
The components of lease expense are as follows:
Operating lease cost
2,239
1,391
4,284
2,772
9
Supplemental cash flow information related to leases is as follows:
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases
3,802
2,691
Supplemental balance sheet information related to leases is as follows:
Weighted-average remaining lease term of operating leases
5.7 years
2.4 years
Weighted-average discount rate of operating leases
2.3%
4.2%
Future minimum lease payments under non-cancelable leases as of July 1, 2022 are as follows:
2022, remaining
4,217
2023
7,322
2024
6,603
2025
5,991
2026
5,510
Thereafter
8,599
Total future minimum lease payments
38,242
Less imputed interest
(2,223
Total lease liabilities
36,019
Note 6 – Income Taxes
Income tax information for the periods reported are as follows:
Effective income tax rate
7.5
%
3.1
7.9
5.7
Our effective tax rates for the three and six months ended July 1, 2022 and June 25, 2021 differ from the statutory rate primarily due to taxes on foreign income that differ from the U.S. tax rate, including a tax holiday in Singapore, and the impact of share-based compensation activity during the quarter.
The ending balance for the unrecognized tax benefits for uncertain tax positions was approximately $3.8 million at July 1, 2022. The related interest and penalties were insignificant. The uncertain tax positions that are reasonably possible to decrease in the next twelve months are insignificant.
As of July 1, 2022, we were not under examination by tax authorities.
Note 7 – Employee Benefit Programs
401(k) Plan
We sponsor a 401(k) plan available to employees of our U.S.‑based subsidiaries. Participants may make salary deferral contributions not to exceed 50% of a participant’s annual compensation or the maximum amount otherwise allowed by law. Eligible employees receive a discretionary matching contribution equal to 50% of a participant’s deferral, up to an annual matching maximum of 4% of a participant’s annual compensation. Matching contributions were $0.7 million and $0.5 million for the second quarter of 2022 and 2021, respectively. Matching contributions were $1.6 million and $1.1 million for the six months ended July 1, 2022 and June 25, 2021, respectively.
10
Note 8 – Long-Term Debt
Long‑term debt consists of the following:
Term loan
146,250
150,000
Revolving credit facility
160,000
145,000
Total principal amount of long-term debt
306,250
295,000
Less unamortized debt issuance costs
(2,014
(2,247
Total long-term debt, net
304,236
292,753
Less current portion
(7,500
Total long-term debt, less current portion, net
On October 29, 2021, we entered into an amended and restated credit agreement, which includes a group of financial institutions as direct lenders underlying the agreement. The credit agreement includes a $150.0 million term loan facility and a $250.0 million revolving credit facility (together, “credit facilities”). Term loan principal payments of $1.9 million are due on a quarterly basis. The credit facilities mature on October 29, 2026.
Interest is charged at either the Base Rate or the Bloomberg Short-Term Bank Yield (“BSBY”) Rate (as such terms are defined in the credit agreement) at our option, plus an applicable margin. The Base Rate is equal to the higher of i) the Prime Rate, ii) the Federal Funds Rate plus 0.5%, or iii) the BSBY Rate plus 1.00%. The applicable margin on Base Rate and BSBY Rate loans is 0.375‑1.375% and 1.375‑2.375% per annum, respectively, depending on our leverage ratio. We are also charged a commitment fee of 0.175%-0.350% on the unused portion of our revolving credit facility. Base Rate interest payments and commitment fees are due quarterly. BSBY Rate interest payments are due on the last day of the applicable interest period, or quarterly for applicable interest periods longer than 3 months. At July 1, 2022, our credit facilities bore interest under the BSBY rate option of 3.44%.
Note 9 – Share‑Based Compensation
The 2016 Omnibus Incentive Plan (the “2016 Plan”) provides for grants of share‑based awards to employees, directors, and consultants. Awards may be in the form of stock options (“options”), tandem and non‑tandem stock appreciation rights, restricted share awards or restricted share units (“RSUs”), performance awards, and other share‑based awards. Forfeited or expired awards are returned to the incentive plan pool for future grants. Awards generally vest over four years, 25% on the first anniversary of the date of grant and quarterly thereafter over the remaining 3 years. Upon vesting of RSUs, employees may elect to have shares withheld to cover statutory minimum withholding taxes. Shares withheld are not reflected as an issuance of ordinary shares within our consolidated statements of shareholders’ equity, as the shares were never issued, and the associated tax payments are reflected as financing activities within our consolidated statements of cash flows.
Share‑based compensation expense across all plans for options, RSUs, and employee share purchase rights was $3.5 million and $2.7 million for the second quarter of 2022 and 2021, and was $6.4 million and $5.1 million for the six months ended July 1, 2022 and June 25, 2021, respectively.
Stock Options
The following table summarizes option activity:
Number of Stock Options
Service
condition
Weighted average exercise price per share
Weighted average remaining contractual term
Aggregate intrinsic value
Outstanding, December 31, 2021
921,469
23.20
Granted
Exercised
(47,768
21.73
Forfeited or expired
(21,775
23.24
Outstanding, July 1, 2022
851,926
23.28
3.4 years
556
Exercisable, July 1, 2022
663,985
23.16
3.1 years
519
11
Restricted Share Units
The following table summarizes RSU activity:
Number of Restricted Share Units
Performance
Market
Weighted average grant-date fair value per share
Unvested, December 31, 2021
559,310
9,716
14,572
37.05
556,600
47,846
71,770
27.49
Vested
(138,437
36.03
Forfeited
(58,923
33.20
Unvested, July 1, 2022
918,550
57,562
86,342
31.31
Employee Share Purchase Plan
The 2017 Employee Stock Purchase Plan (the “2017 ESPP”) grants employees the ability to designate a portion of their base-pay to purchase ordinary shares at a price equal to 85% of the fair market value of our ordinary shares on the first or last day of each 6 month purchase period. Purchase periods begin on January 1 or July 1 and end on June 30 or December 31, or the next business day if such date is not a business day. Shares are purchased on the last day of the purchase period.
As of July 1, 2022, approximately 2.3 million ordinary shares remain available for purchase under the 2017 ESPP.
Note 10 – Earnings per Share
The following table sets forth the computation of basic and diluted earnings per share and a reconciliation of the numerator and denominator used in the calculation:
Numerator:
Denominator:
Basic weighted average ordinary shares outstanding
Dilutive effect of options
148,160
601,871
215,582
550,059
Dilutive effect of RSUs
228,107
298,499
102,871
288,978
Dilutive effect of ESPP
322
11,330
Diluted weighted average ordinary shares outstanding
Securities excluded from the calculation of diluted weighted average ordinary shares outstanding (1)
721,000
185,000
915,000
Earnings per share:
Net income:
(1)
Represents potentially dilutive options and RSUs excluded from the calculation of diluted weighted average ordinary shares outstanding, because including them would have been antidilutive under the treasury stock method.
12
Note 11 – Segment Information
Our Chief Operating Decision Maker, the Chief Executive Officer, reviews our results of operations on a consolidated level and executive staff is structured by function rather than by product category. Additionally, key resources, decisions, and assessment of performance are analyzed at a company‑wide level. Therefore, we operate in one operating segment.
Foreign operations are conducted primarily through our wholly owned subsidiaries in Singapore and Malaysia, and to a lesser degree, Scotland, Korea, and Mexico. Our principal markets include North America, Asia, and to a lesser degree, Europe.
Sales by geographic area represents sales to unaffiliated customers based upon the location to which the products were shipped. The following table sets forth sales by geographic area:
United States of America
158,374
137,747
300,844
276,881
Singapore
114,398
101,214
217,693
187,538
Europe
24,806
22,439
49,198
39,769
31,982
20,908
54,971
42,686
Total net sales
Foreign long-lived assets, exclusive of deferred tax assets, were $42.2 million and $38.4 million at July 1, 2022 and December 31, 2021, respectively.
13
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Cautionary Statement Concerning Forward-Looking Statements
This report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. You should not place undue reliance on these statements. All statements other than statements of historical fact included in this report are forward-looking statements. These statements relate to analyses and other information, which are based on forecasts of future results and estimates of amounts not yet determinable. These statements also relate to our future prospects, developments and business strategies. These forward-looking statements are identified by the use of terms and phrases such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “will” and similar terms and phrases, including references to assumptions. However, these words are not the exclusive means of identifying such statements. These statements are contained in many sections of this report, including those in Part I – Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations. Although we believe that our plans, intentions and expectations reflected in or suggested by such forward-looking statements are reasonable, we cannot assure you that we will achieve those plans, intentions or expectations. All forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those that we expected. Important factors that could cause actual results to differ materially from our expectations, or cautionary statements, include geopolitical, economic and market conditions, including heightened inflation, slower growth or recession, changes to fiscal and monetary policy, higher interest rates, currency fluctuations, challenges in the supply chain and any disruptions in European economies as a result of the conflict in Ukraine; our dependence on expenditures by manufacturers in the semiconductor capital equipment industry; our reliance on a very small number of original equipment manufacturer customers for a significant portion of our sales; our customers’ significant negotiating leverage; competition in our industry; and other factors set forth in this report, and those set forth in Part I – Item 1A. Risk Factors of our 2021 Annual Report on Form 10‑K and our other filings with the Securities and Exchange Commission (“SEC”). All written and oral forward-looking statements attributable to us, or persons acting on our behalf, are expressly qualified in their entirety by the cautionary statements contained in Part I – Item 1A. Risk Factors to our 2021 Annual Report on Form 10-K, as well as other cautionary statements that are made from time to time in our other filings with the SEC and public communications. You should evaluate all forward-looking statements made in this report in the context of these risks and uncertainties.
We caution you that the important factors referenced above may not contain all of the factors that are important to you. In addition, we cannot assure you that we will realize the results or developments we expect or anticipate or, even if substantially realized, that they will result in the consequences or affect us or our operations in the way we expect. The forward-looking statements included in this report are made only as of the date hereof. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.
You should read the following discussion and analysis of our financial condition and results of operations in conjunction with our consolidated unaudited financial statements and related notes included elsewhere in this report.
Overview
We are a leader in the design, engineering, and manufacturing of critical fluid delivery subsystems and components for semiconductor capital equipment. Our product offerings include gas and chemical delivery systems and subsystems, collectively known as fluid delivery systems and subsystems, which are key elements of the process tools used in the manufacturing of semiconductor devices. Our gas delivery subsystems deliver, monitor, and control precise quantities of the specialized gases used in semiconductor manufacturing processes such as etch and deposition. Our chemical delivery systems and subsystems precisely blend and dispense the reactive liquid chemistries used in semiconductor manufacturing processes such as chemical-mechanical planarization, electroplating, and cleaning. We also provide precision-machined components, weldments, e‑beam and laser-welded components, precision vacuum and hydrogen brazing and surface treatment technologies, and other proprietary products. This vertically integrated portion of our business is primarily focused on metal and plastic parts that are used in gas and chemical systems, respectively.
Fluid delivery subsystems ensure accurate measurement and uniform delivery of specialty gases and chemicals at critical steps in the semiconductor manufacturing processes. Any malfunction or material degradation in fluid delivery reduces yields and increases the likelihood of manufacturing defects in these processes. Most OEMs outsource all or a portion of the design, engineering, and manufacturing of their gas delivery subsystems to a few specialized suppliers, including us. Additionally, many OEMs are outsourcing the design, engineering, and manufacturing of their chemical delivery subsystems due to the increased fluid expertise required to manufacture these subsystems. Outsourcing these subsystems has allowed OEMs to leverage the suppliers’ highly specialized engineering, design, and production skills while focusing their internal resources on their own value-added processes. We believe that this outsourcing trend has enabled OEMs to reduce their costs and development time, as well as provide growth opportunities for specialized subsystems suppliers like us.
We have a global footprint with production facilities in California, Minnesota, Oregon, Texas, Singapore, Malaysia, the United Kingdom, Korea, and Mexico.
The following table summarizes key financial information for the periods indicated. Amounts are presented in accordance with GAAP unless explicitly identified as being a non-GAAP metric. For a description of our non-GAAP metrics and reconciliations to the most comparable GAAP metrics, please refer to Part I – Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Non-GAAP Financial Results within this report.
Gross margin
16.8
16.0
15.9
Non-GAAP gross margin
17.0
16.5
Operating expenses
Non-GAAP net income
28,326
26,307
48,504
48,032
Diluted EPS
Non-GAAP diluted EPS
0.98
0.90
1.68
1.66
Macroeconomic Conditions and COVID-19 Pandemic Update
Adverse macroeconomic conditions, including but not limited to heightened inflation, slower growth or recession, changes to fiscal and monetary policy, higher interest rates, currency fluctuations and challenges in the supply chain have created, and are expected to continue to create significant volatility, uncertainty, and turmoil in our industry. Further, the war in Ukraine has given rise to potential global security issues that may adversely affect international business and economic conditions as well as economic sanctions imposed by the international community that have impacted the global economy. We and certain of our customers may be negatively impacted by these events.
In addition, the impact that the COVID‑19 pandemic and associated macroeconomic conditions, including those discussed above, will have on our consolidated results of operations for the remainder of 2022 contains to remain uncertain. While our facilities are currently not subject to any site-wide government shutdowns, and restrictions have eased around social, business, travel, and governmental activities, we have experienced increases in direct costs and inefficiencies within our factories associated with logistics, employee labor, and certain component shortages. These factors have resulted in, and may continue to result in, lower revenues and operating margins. The extent and duration of these impacts cannot be specifically quantified given the dynamic nature and breadth of the pandemic’s impact on our operations and those of our customers and suppliers.
15
Results of Operations
The following table sets forth our unaudited results of operations for the periods presented. The period‑to‑period comparison of results is not necessarily indicative of results for future periods.
The following table sets forth our unaudited results of operations as a percentage of our total sales for the periods presented.
100.0
83.2
84.0
84.1
1.5
1.4
1.6
6.4
5.2
7.1
5.3
1.2
9.3
7.8
10.3
8.9
0.6
(0.2
0.0
(0.1
8.4
7.3
0.5
0.3
0.4
6.5
8.1
4.7
6.9
Comparison of the three months ended July 1, 2022 and June 25, 2021
Net Sales
Change
47,252
16.7
75,832
13.9
The increase in net sales from the three and six months ended June 25, 2021 to the three and six months ended July 1, 2022 was primarily due to strong demand from our customers as a result of continued growth in the global wafer fabrication equipment market, supported by capacity expansions and headcount additions we have made over the last year, as well as incremental revenues from our acquisition of IMG Companies, LLC (“IMG”) in November 2021.
16
Cost of Sales, Gross Profit, and Gross Margin
39,144
63,304
13.8
8,108
17.1
12,528
14.4
n/c
+ 10 bps
The increase in the gross amounts of cost of sales and gross profit from the three and six months ended June 25, 2021 to the three and six months ended July 1, 2022 was primarily due to the factors mentioned in the commentary above under the heading, “Net Sales.”
Our gross margin was flat from the second quarter of 2021 to the second quarter of 2022, and up 10 basis points from the six months ended June 25, 2021 to the six months ended July 1, 2022, primarily due to accretive margins from our acquisition of IMG in November 2021, offset by increased materials, logistics, and labor costs, as we invest in our capacity to service present levels of strong customer demand in future quarters, and the impacts of component and material shortages, due to supply chain challenges, thereby reducing factory utilization.
Research and Development
858
21.2
2,194
29.0
The increase in research and development expenses from the three and six months ended June 25, 2021 to the three and six months ended July 1, 2022 was primarily due to increased employee-related expense, inclusive of share-based compensation expense, of $0.7 million and $1.7 million, respectively, as we expand our engineering team to design and engineer next generation, high performance solutions for our customers, as well as program costs related to the development of our new products of $0.1 million and $0.3 million, respectively.
Selling, General, and Administrative
6,404
43.6
15,322
52.7
The increase in selling, general, and administrative expense from the second quarter of 2021 to the second quarter of 2022 was primarily due to (1) incremental costs from our acquisition of IMG in November 2021 of $3.1 million, primarily consisting of employee-related expenses; (2) increased employee-related expenses, inclusive of share-based compensation expense, of $2.1 million; (3) increased depreciation and occupancy costs of $0.8 million; and (4) increased consulting and professional fees of $0.5 million.
The increase in selling, general, and administrative expense from the six months ended June 25, 2021 to the six months ended July 1, 2022 was primarily due to (1) incremental costs from our acquisition of IMG in November 2021 of $6.3 million, primarily consisting of employee-related expenses; (2) increased employee-related expenses, inclusive of share-based compensation expense, of $3.8 million; (3) a non-recurring loss accrual recorded in the first quarter of 2022 relating to an expected settlement of an employment-related legal matter of $3.1 million; (4) increased depreciation and occupancy costs of $1.2 million; and (5) increased consulting and professional fees of $1.2 million.
Amortization of Intangible Assets
Amortization of intangibles assets
1,265
37.3
3,223
47.5
17
The increase in amortization expense from the three and six months ended June 25, 2021 to the three and six months ended July 1, 2022 was primarily due to incremental amortization expense from intangible assets acquired in connection with our acquisition of IMG in November 2021, partially offset by reduced amortization expense from certain intangible assets becoming fully amortized in the fourth quarter of 2021 and the first quarter of 2022.
Interest Expense, Net
472
29.7
85
2.4
Weighted average borrowings outstanding
306,600
168,008
138,592
82.5
300,780
178,992
121,788
68.0
Weighted average borrowing rate
2.43
3.01
- 58 bps
2.13
3.16
- 103 bps
The increase in interest expense, net from the three and six months ended June 25, 2021 to the three and six months ended July 1, 2022 was primarily due to an increase of $138.6 million and $121.8 million in our average amount borrowed during the during the three and six months ended July 1, 2022, respectively, compared to the three and six months ended June 25, 2021. This was partially offset by a decrease of 58 basis points and 103 basis points in our weighted average borrowing rate during the three and six months ended July 1, 2022, respectively, compared to the three and six months ended June 25, 2021, as well as a decrease in debt issuance cost amortization expense.
Our average amount borrowed was primarily the result of drawing $130.0 million on our revolving credit facility in November 2021 to partially fund our acquisition of IMG. The decrease in our weighted average borrowing rate was primarily due to more favorable borrowing terms under our October 2021 amended and restated credit agreement, partially offset by overall higher prevailing BSBY and LIBOR rates in the second quarter of 2022 compared to 2021.
Other Expense (Income), Net
(570
n/m
(671
The change in other expense (income), net from the three and six months ended June 25, 2021 to the three and six months ended July 1, 2022 was primarily due to currency exchange rate fluctuations during the quarter, reflecting a strengthening U.S. dollar against local currency payables of our foreign operations.
Income Tax Expense
1,007
136.6
302
13.4
(321
-1.4
(7,625
-19.2
+ 440 bps
+ 220 bps
The increase in income tax expense from the three and six months ended June 25, 2021 to the three and six months ended July 1, 2022 was primarily due reduced benefits from share-based compensation activity. This was primarily driven by RSU awards vesting at lower fair values in 2022 compared to their corresponding grant-date fair values. In 2021, RSU awards vested at higher fair values compared to their corresponding grant-date fair values.
18
Non‑GAAP Financial Results
Management uses non-GAAP metrics to evaluate our operating and financial results. We believe the presentation of non-GAAP results is useful to investors for analyzing business trends and comparing performance to prior periods, along with enhancing investors’ ability to view our results from management’s perspective. Non-GAAP gross margin is defined as non-GAAP gross profit divided by net sales. Non-GAAP gross profit and non-GAAP net income are defined as: gross profit or net income excluding, as applicable, (1) amortization of intangible assets, share-based compensation expense, and non-recurring expenses, including settlement losses, facility shutdown costs, and acquisition-related costs and charges, to the extent they are present in gross profit or net income; and (2) the tax impacts associated with our non-GAAP adjustments, as well as non-recurring discrete tax items. Non-GAAP diluted earnings per share (“EPS”) is defined as non-GAAP net income divided by weighted average diluted ordinary shares outstanding during the period.
Non-GAAP results have limitations as an analytical tool, and you should not consider them in isolation or as a substitute for our results reported under GAAP. Other companies may calculate non-GAAP results differently or may use other measures to evaluate their performance, both of which could reduce the usefulness of our non-GAAP results as a tool for comparison.
Because of these limitations, you should consider non-GAAP results alongside other financial performance measures and results presented in accordance with GAAP. In addition, in evaluating non-GAAP results, you should be aware that in the future we will incur expenses such as those that are the subject of adjustments in deriving non-GAAP results and you should not infer from our presentation of non-GAAP results that our future results will not be affected by these expenses or any unusual or non-recurring items.
The following table presents our unaudited non‑GAAP gross profit and non-GAAP gross margin and a reconciliation from gross profit, the most comparable GAAP measure, for the periods indicated:
U.S. GAAP gross profit
Non-GAAP adjustments:
451
298
1,002
604
Facility shutdown costs (1)
(102
2,297
Fair value adjustment to inventory from acquisitions (2)
2,492
211
Other non-recurring expense, net (3)
106
Non-GAAP gross profit
55,912
47,549
102,887
90,083
U.S. GAAP gross margin
During the second quarter of 2020, we announced the closure of our manufacturing facility in Union City, California, which we completed in 2021. Included in this amount for the second quarter of 2021 is a gain realized upon the sale of equipment and other fixed assets, partially offset by write-off costs associated with inventories determined during the quarter to be obsolete. Included in this amount for the six months ended June 25, 2021 are write-off costs associated with inventories determined during the period to be obsolete and severance and other shutdown related charges, partially offset by a gain realized upon the sale of equipment and other fixed assets.
(2)
As part of the purchase price allocations of our acquisitions of IMG in November 2021 and a precision machining operation in Mexico in December 2020, we recorded acquired-inventories at fair value, resulting in a fair value step-up of $3.9 million and $0.2 million, respectively. These amounts were subsequently released to cost of sales as acquired-inventories were sold.
(3)
Included in this amount for the six months ended June 25, 2021 is primarily a non-recurring settlement charge.
19
The following table presents our unaudited non‑GAAP net income and non-GAAP diluted EPS and a reconciliation from net income, the most comparable GAAP measure, for the periods indicated:
U.S. GAAP net income
172
2,682
Settlement loss (2)
3,100
Fair value adjustment to inventory from acquisitions (3)
Acquisition costs (4)
296
Other non-recurring expense, net (5)
110
388
Tax adjustments related to non-GAAP adjustments (6)
(1,396
(2,911
(3,370
(4,629
U.S. GAAP diluted EPS
Shares used to compute diluted EPS
See footnote 1 to the reconciliation of U.S. GAAP gross profit to non-GAAP gross profit above.
During the first quarter of 2022, we recorded a non-recurring loss accrual of $3.1 million relating to an expected settlement of an employment-related legal matter. We expect the settlement to be finalized and paid within the next 12 months.
See footnote 2 to the reconciliation of U.S. GAAP gross profit to non-GAAP gross profit above.
(4)
Included in this amount are incremental transaction-related costs incurred in connection with our acquisition of IMG in November 2021.
(5)
Included in this amount for the six months ended June 25, 2021 are primarily (i) non-capitalized costs incurred in connection with our implementation of a new ERP system and a Sarbanes-Oxley compliance program and (ii) a non-recurring settlement charge.
(6)
Adjusts U.S. GAAP income tax expense (benefit) for impact of our non-GAAP adjustments, as defined, including the impacts of excluding share-based compensation, amortization of intangible assets, and other non-recurring expenses. This adjustment also excludes the impact of non-recurring discrete tax items.
Liquidity and Capital Resources
The following section discusses our liquidity and capital resources, including our primary sources of liquidity and our material cash requirements. Our cash and cash equivalents are maintained in highly liquid and accessible accounts with no significant restrictions.
Material Cash Requirements
Our primary liquidity requirements arise from: (i) working capital requirements, including procurement of raw materials inventory for use in our factories and employee-related costs, (ii) business acquisitions, (iii) interest and principal payments under our credit facilities, (iv) research and development investments and capital expenditures, and (v) payment of income taxes. We have no significant long-term purchase commitments related to procuring raw materials inventory. Our ability to fund these requirements will depend, in part, on our future cash flows, which are determined by our future operating performance and are therefore subject to prevailing global macroeconomic conditions and financial, business, and other factors, some of which are beyond our control.
We believe that our cash and cash equivalents, the amounts available under our credit facilities, and our operating cash flow will be sufficient to fund our business and our current obligations for at least the next 12 months and beyond.
Sources and Conditions of Liquidity
Our ongoing sources of liquidity to fund our material cash requirements are primarily derived from: (i) sales to our customers and the related changes in our net operating assets and liabilities and (ii) proceeds from our credit facilities and equity offerings, when applicable.
20
Summary of Cash Flows
We ended the second quarter of 2022 with cash and cash equivalents of $46.1 million, a decrease of $29.4 million from December 31, 2021. The decrease was primarily due to cash used in operating activities of $26.9 million and capital expenditures of $14.4 million, partially offset by net proceeds from our credit facilities of $11.3 million.
The following table sets forth a summary of operating, investing, and financing activities for the periods presented:
Cash provided by (used in) operating activities
Cash used in investing activities
Cash provided by (used in) financing activities
Our cash used in operating activities of $26.9 million during the six months ended July 1, 2022 consisted of an increase in our net operating assets and liabilities of $80.4 million, partially offset by net income of $29.6 million and net non-cash charges of $23.9 million, primarily consisting of depreciation and amortization of $18.4 million and share-based compensation expense of $6.4 million.
The increase in our net operating assets and liabilities during the six months ended July 1, 2022, net of acquisitions, was primarily due to an increase in inventories of $54.2 million, an increase in accounts receivable of $15.4 million, and a decrease in accounts payable of $12.5 million. The increase in our inventories is primarily driven by elevated purchasing activity pursuant to strong customer demand and certain supply chain component constraints. The decrease in accounts payable and increase in accounts receivable were primarily due to fluctuations in payment timing to suppliers and from customers, as well as higher revenues in the last few weeks of the second quarter of 2022 compared to the last few weeks of the fourth quarter of 2021.
Cash used in investing activities during the six months ended July 1, 2022 consists of capital expenditures.
Cash provided by financing activities during the six months ended July 1, 2022 consists of net proceeds from our credit facilities of $11.3 million, including a net draw on our revolving facility of $15.0 million for U.S. working capital obligations, and net proceeds from share-based compensation activity of $0.6 million.
Critical Accounting Estimates
Our consolidated financial statements have been prepared in accordance with U.S. GAAP. The preparation of these consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, sales, expenses, and related disclosures. We base our estimates on historical experience and on various other assumptions that we believe are reasonable under the circumstances. We evaluate our estimates and assumptions on an ongoing basis. Actual results may differ from these estimates. To the extent that there are material differences between these estimates and our actual results, our future financial statements will be affected.
The critical accounting policies requiring estimates, assumptions, and judgments that we believe have the most significant impact on our consolidated financial statements are identified and described in our annual consolidated financial statements and the notes included in our 2021 Annual Report on Form 10‑K.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Foreign Currency Exchange Risk
Substantially all of our sales arrangement with customers, and the significant majority of our arrangements with third-party suppliers, provide for pricing and payment in U.S. dollars and, therefore, are not subject to material exchange rate fluctuations. As a result, we do not expect foreign currency exchange rate fluctuations to have a material effect on our results of operations. However, increases in the value of the U.S. dollar relative to other currencies would make our products more expensive relative to competing products priced in such other currencies, which could negatively impact our ability to compete. Conversely, decreases in the value of the U.S. dollar relative to other currencies could result in our foreign suppliers raising their prices in order to continue doing business with us.
We do have certain operating expenses that are denominated in currencies of the countries in which our operations are located, and may be subject to fluctuations due to foreign currency exchange rates, particularly the Singapore dollar, Malaysian ringgit, British pound, euro, Korean won, and Mexican peso. Fluctuations in foreign currency exchange rates may cause us to recognize transaction gains and losses in our statement of operations. To date, foreign currency transaction gains and losses have not been material to our financial statements, and we have not engaged in any foreign currency hedging transactions.
Interest Rate Risk
We had total indebtedness of $306.3 million as of July 1, 2022, exclusive of $2.0 million in debt issuance costs, of which $7.5 million was due within 12 months. We do not enter into investments for trading or speculative purposes and have not used any derivative financial instruments to manage our interest rate risk exposure. We have not been exposed to, nor do we anticipate being exposed to, material risks due to changes in interest rates. As of July 1, 2022, the interest rate on our outstanding debt is based on BSBY, plus an applicable rate depending on our leverage ratio. A hypothetical 100 basis point change in the interest rate on our outstanding debt would have resulted in a $0.8 million change to interest expense during the second quarter of 2022, or $3.1 million on an annualized basis.
ITEM 4. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
We carried out an evaluation under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer (the certifying officers), of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a‑15(e) and 15d‑15(e) under the Securities and Exchange Act, as amended (“the Exchange Act”)) as of December 31, 2021. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance of achieving their control objectives. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of July 1, 2022, due to material weaknesses in internal control over financial reporting that were disclosed in Part II – Item 9A of our Annual Report on Form 10‑K for the fiscal year ended December 31, 2021.
Limitations on Effectiveness of Controls and Procedures
A company’s internal control over financial reporting is a process designed by, or under the supervision of, a company’s principal executive and principal financial officers, or persons performing similar functions, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with GAAP. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. In addition, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with policies or procedures may deteriorate. If we cannot provide reliable financial information, our business, operating results, and share price could be negatively impacted.
Changes in Internal Control Over Financial Reporting
There have been no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) during the period covered under this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Remediation
As previously described in Part II – Item 9A of our Annual Report on Form 10‑K for the fiscal year ended December 31, 2021, we began implementing a remediation plan to address the material weaknesses mentioned above. The weaknesses will not be considered remediated until the applicable controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively. We expect that the remediation of these material weaknesses will be completed prior to the end of fiscal year 2022.
PART II—OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
We are currently not a party to any material pending or threatened litigation.
ITEM 1A. RISK FACTORS
This quarterly report should be read in conjunction with the risk factors included in our 2021 Annual Report on Form 10‑K. There have been no material changes in our risk factors from the risk factors disclosed in that report. These risk factors do not identify all risks that we face – our operations could also be affected by factors that are not presently known to us or that we currently consider to be immaterial to our operations. Due to risks and uncertainties, known and unknown, our past financial results may not be a reliable indicator of future performance and historical trends should not be used to anticipate results or trends in future periods.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
None.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
ITEM 5. OTHER INFORMATION
ITEM 6. EXHIBITS
Exhibit
Number
Description
3.1*
Amended and Restated Memorandum and Articles of Association of Ichor Holdings, Ltd., effective as of May 24, 2022.
31.1*
Certification of Principal Executive Officer Pursuant to Rules 13a‑14(a) and 15d‑14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes‑Oxley Act of 2002.
31.2*
Certification of Principal Financial Officer Pursuant to Rules 13a‑14(a) and 15d‑14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes‑Oxley Act of 2002.
32.1**
Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes‑Oxley Act of 2002.
32.2**
Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes‑Oxley Act of 2002.
101.INS*
Inline XBRL Instance Document
101.SCH*
Inline XBRL Taxonomy Extension Schema Document
101.CAL*
Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*
Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*
Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE*
Inline XBRL Taxonomy Extension Presentation Linkbase Document
104
Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101)
*
Filed herewith.
**
Furnished herewith and not filed.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date: August 10, 2022
By:
/s/ Jeffrey S. Andreson
Jeffrey S. Andreson
Chief Executive Officer
(Principal Executive Officer)
/s/ Larry J. Sparks
Larry J. Sparks
Chief Financial Officer
(Principal Accounting and Financial Officer)